◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Olympus Corporation (7733)

Name: Olympus Corporation（7733）— 财务报表历史
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

来自官方财务报表的收入、利润与现金流历史。

Healthcare · 华尔街（美国） · 最近更新： 2026-10-02

Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products.

关键数据

市值: JPY 2.08 trillion
收入（截至 2026-03-31 财年）: JPY 1.01T
净利润: JPY 68.2B
毛利率: 64.7%
净利率: 6.7%

查看交互式图表与完整报表 → 估值模型 (DCF) →

年度利润表

利润表	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
总收入	JPY 1.01T	JPY 997.3B	JPY 925.8B	JPY 881.9B	—
毛利	JPY 654.1B	JPY 683.7B	JPY 618.4B	JPY 596.8B	—
营业利润（EBIT）	JPY 100.8B	JPY 162.0B	JPY 51.7B	JPY 186.1B	—
净利	JPY 68.2B	JPY 117.9B	JPY 242.6B	JPY 143.4B	—

来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。

资产负债表、现金流、季度数据与完整财务比率见 7733 交互式查看器。 /companies/us/7733

类似公司

本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。

English version →全部股票

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.